Indonesia says about 100 mln AstraZeneca vaccine doses face arrival delays

Indonesia's health minister said on Thursday the schedule for around 100 million doses of AstraZeneca's COVID-19 vaccines faced delays, as an official warned that supply issues could hamper the country's inoculation programme. Health minister Budi Gunadi Sadikin told a parliamentary hearing that Indonesia would receive 20 million doses of the AstraZeneca vaccine via a bilateral deal in 2021, instead of the 50 million doses initially agreed.

Reuters | Jakarta | Updated: 08-04-2021 11:26 IST | Created: 08-04-2021 11:12 IST
Indonesia says about 100 mln AstraZeneca vaccine doses face arrival delays
Representative image Image Credit: ANI

Indonesia's health minister said on Thursday the schedule for around 100 million doses of AstraZeneca's COVID-19 vaccines faced delays, as an official warned that supply issues could hamper the country's inoculation program.

Health minister Budi Gunadi Sadikin told a parliamentary hearing that Indonesia would receive 20 million doses of the AstraZeneca vaccine via a bilateral deal in 2021, instead of the 50 million doses initially agreed. The remaining 30 million doses were due to be shipped by the second quarter of 2022, he said. Indonesia is also slated to receive 54 million doses of the AstraZeneca vaccine in phases via the COVAX global-vaccine alliance scheme, though Budi said Indian export restrictions would delay shipments in April.

"That's something that we cannot accept and we're negotiating with AstraZeneca. So that's 100 million doses of vaccine whose schedule remains unclear," he said. AstraZeneca did not immediately respond to a request for comment. The corporate secretary of state-owned pharmaceutical company Bio Farma, which is distributing the vaccine, declined to comment ahead of a statement from its chief executive. Budi said that due to the delays the rate of vaccination would need to be accelerated between May and June and available doses would be earmarked for the elderly and teachers. Siti Nadia Tarmizi, a senior health ministry official, told Reuters the delays could impact Indonesia's program "if we don't get other vaccines as replacements."

Besides AstraZeneca, Indonesia relies heavily on vaccines produced by China's Sinovac Biotech for its vaccination program, which began in January and aims to reach 181.5 million people within a year in a bid to reach herd immunity. Indonesia has administered at least one shot of vaccine to over 9.22 million people.

The Southeast Asian country has been struggling to get under control one of Asia's worst epidemics, having reported over 1.54 million coronavirus cases and 42,000 deaths as of Wednesday.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...

Videos

Latest News

Fuel rates controlled before polls, but raised later: Maha minister

Maharashtra Water Resources Minister Jayant Patil on Wednesday hit out at the Centre over the fuel price hike, claiming the rates of petrol and diesel are controlled ahead of elections but increased after polls get over.Patil, who is also t...

Court rules Air France, Airbus should stand trial over 2009 crash - prosecutor

A French court has ruled that Air France and Airbus should stand trial over a 2009 crash in the Atlantic Ocean which killed 228 people, a judicial source from the prosecutors department said on Wednesday.The court, ruling on a request from ...

U.S. returns $460 mln in recovered 1MDB funds to Malaysia

Malaysia on Wednesday said the U.S. Department of Justice has returned 1.9 billion ringgit 460.22 million of funds recovered from assets related to sovereign fund 1Malaysia Development Berhad 1MDB.Malaysian and U.S. investigators say at lea...

Airbus revives plan for new single-aisle jet plant in Toulouse

Airbus has revived plans for a new production line for its A321neo jet in Toulouse, France, as it reshapes production of the medium-haul single-aisle jets that it hopes will lead its factories out of the coronavirus crisis. The European pla...

Give Feedback